These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3322730)

  • 21. Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects.
    James RW; Pometta D
    Diabetes; 1990 Oct; 39(10):1158-64. PubMed ID: 2210068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous subcutaneous insulin infusion (Mill-Hill Infuser) versus multiple injections (Medi-Jector) in the treatment of insulin-dependent diabetes mellitus and the effect of metabolic control on microangiopathy.
    Chiasson JL; Ducros F; Poliquin-Hamet M; Lopez D; Lecavalier L; Hamet P
    Diabetes Care; 1984; 7(4):331-7. PubMed ID: 6381006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of insulin treatment on lipoprotein composition and function in patients with IDDM.
    Bagdade JD; Dunn FL
    Diabetes; 1992 Oct; 41 Suppl 2():107-10. PubMed ID: 1526328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term treatment by implantable pump does not impair lipoprotein pattern in IDDM patients.
    Hanaire-Broutin H; Lorenzini F; Lacombe S; Lafon F; Solera ML; Tauber JP
    Transplant Proc; 1992 Jun; 24(3):947. PubMed ID: 1604677
    [No Abstract]   [Full Text] [Related]  

  • 25. Are plasma lipoproteins responsible for the excess atherosclerosis in diabetes?
    Nikkilä EA
    Acta Endocrinol Suppl (Copenh); 1985; 272():27-30. PubMed ID: 3869424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial.
    Am J Cardiol; 1995 May; 75(14):894-903. PubMed ID: 7732997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early atherogenesis in diabetes mellitus.
    Schaper NC
    Diabet Med; 1996; 13 Suppl 1():S23-5. PubMed ID: 8741824
    [No Abstract]   [Full Text] [Related]  

  • 28. [Changes in HDL subfractions in patients with type I diabetes mellitus before and after metabolic control].
    Pacifico A; Cherchi GM; Baggi MA; Deiana MG; Maioli M
    Boll Soc Ital Biol Sper; 1983 Nov; 59(11):1618-24. PubMed ID: 6365116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes of lipoproteins during insulin therapy in diabetes mellitus type 1].
    Pantelinac P
    Med Pregl; 2009; 62 Suppl 3():66-9. PubMed ID: 19702119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of hyperbaric oxygenation on the dynamics of carbohydrate and lipid metabolism in the blood of patients with type I diabetes mellitus].
    Lukich BL; Kakhnovskiĭ IM; Kurakina LV; Murakhovskiĭ KK
    Klin Med (Mosk); 1994; 72(3):46-50. PubMed ID: 7990355
    [No Abstract]   [Full Text] [Related]  

  • 31. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
    J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycemic Control and Excess Cardiovascular Mortality in Type 1 Diabetes.
    Teleb M; Popp Switzer M; Elhanafi S; Elfar A; San Juan ZT
    Curr Cardiol Rep; 2016 Mar; 18(3):29. PubMed ID: 26886228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes.
    Paty BW
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S155-9. PubMed ID: 26654859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients.
    Mayfield RK; Halushka PV; Wohltmann HJ; Lopes-Virella M; Chambers JK; Loadholt CB; Colwell JA
    Diabetes; 1985 Nov; 34(11):1127-33. PubMed ID: 3930325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma insulin and serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects.
    Laakso M; Pyörälä K; Voutilainen E; Marniemi J
    Am J Epidemiol; 1987 Apr; 125(4):611-21. PubMed ID: 3548333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of insulin delivery devices in diabetes care.
    Garg SK
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S1-3. PubMed ID: 20515296
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment with artificial beta-cell decreases very-low-density lipoprotein triglyceride synthesis in type I diabetes.
    Dunn FL; Carroll PB; Beltz WF
    Diabetes; 1987 May; 36(5):661-6. PubMed ID: 3552799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma lipid and lipoprotein disorders in IDDM.
    Dunn FL
    Diabetes; 1992 Oct; 41 Suppl 2():102-6. PubMed ID: 1526327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence of beneficial effects of strict glycemic control on diabetic vascular complications--a prospective study with artificial devices.
    Shichiri M; Kawamori R; Goriya Y; Kikuchi M; Bando K; Abe H
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():719-22. PubMed ID: 6680548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atherosclerosis and insulin in primates with diabetes mellitus.
    Howard CF
    Metabolism; 1985 Dec; 34(12 Suppl 1):60-6. PubMed ID: 3906362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.